Copyright
©The Author(s) 2021.
World J Hepatol. Feb 27, 2021; 13(2): 166-186
Published online Feb 27, 2021. doi: 10.4254/wjh.v13.i2.166
Published online Feb 27, 2021. doi: 10.4254/wjh.v13.i2.166
Ref. | No. patients | Median survival, d/mo | Adjuvant therapy |
Ortner et al[106] | PDT 20, Control 19 | 493 d, 98 d | PDT -, Control - |
Zoepf et al[103] | PDT 16, Control 16 | 630 d, 210 d | PDT -, Control - |
Dumoulin et al[100] | PDT 24, Control 23 | 9.9 mo, 5.6 mo | PDT -, Control - |
Kahaleh et al[102] | PDT 19, Control 21 | 8.0 mo, 5.0 mo | PDT, CTX 11; RTX 9; CTX 11, RTX 10 |
Witzigman et al[99] | PDT 68, Control 56 | 12.0 mo, 6.4 mo | PDT, CTX 6; RTX 2; CTX 5, RTX 1 |
- Citation: Tantau AI, Mandrutiu A, Pop A, Zaharie RD, Crisan D, Preda CM, Tantau M, Mercea V. Extrahepatic cholangiocarcinoma: Current status of endoscopic approach and additional therapies. World J Hepatol 2021; 13(2): 166-186
- URL: https://www.wjgnet.com/1948-5182/full/v13/i2/166.htm
- DOI: https://dx.doi.org/10.4254/wjh.v13.i2.166